RANDOMIZED TRIAL OF CYCLOPHOSPHAMIDE, DOXORUBICIN, AND 5-FLUOROURACIL ALONE OR ALTERNATING WITH A CYCLE ACTIVE NON-CROSS-RESISTANT COMBINATION IN WOMEN WITH VISCERAL METASTATIC BREAST-CANCER - A SOUTHEASTERN CANCER STUDY-GROUP PROJECT

被引：27

作者：

VOGEL, CL

SMALLEY, RV

RANEY, M

KRAUSS, S

CARPENTER, J

VELEZGARCIA, E

FISHKIN, E

RAAB, S

MOORE, MR

STAGG, M

机构：

[1] SE CANC STUDY GRP,STAT OFF,BIRMINGHAM,AL

[2] UNIV TENNESSEE,KNOXVILLE,TN 37996

[3] UNIV ALABAMA,BIRMINGHAM,AL 35233

[4] UNIV PUERTO RICO,SAN JUAN,PR 00936

[5] NEW JERSEY MED COLL,NEWARK,NJ

[6] DUKE UNIV,DURHAM,NC 27706

[7] EMORY UNIV,ATLANTA,GA 30322

[8] TEMPLE UNIV,PHILADELPHIA,PA 19122

来源：

JOURNAL OF CLINICAL ONCOLOGY | 1984年 / 2卷 / 06期

关键词：

D O I：

10.1200/JCO.1984.2.6.643

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：643 / 651

页数：9

共 74 条

[1]

ABELOFF MD, 1977, CANCER TREAT REP, V61, P1685

[2]

Ahmann D L, 1978, Cancer Clin Trials, V1, P219

[3]

AISNER J, 1981, P AM ASSOC CANC RES, V22, P443

[4] DOSE-RELATED SYNERGISM OF CYTOSINE-ARABINOSIDE AND METHOTREXATE AGAINST MURINE LEUKEMIA-L1210 [J].

AVERY, TL ;

ROBERTS, D .

EUROPEAN JOURNAL OF CANCER, 1974, 10 (07) :425-429

[5]

BERD D, 1975, CANCER, V35, P1050, DOI 10.1002/1097-0142(197504)35:4<1050::AID-CNCR2820350406>3.0.CO

[6]

2-F

[7]

BRAMBILLA C, 1978, CANCER CHEMOTH PHARM, V1, P35

[8] RESPONSE AND SURVIVAL IN ADVANCED BREAST-CANCER AFTER 2 NON-CROSS-RESISTANT COMBINATIONS [J].

BRAMBILLA, C ;

DELENA, M ;

ROSSI, A ;

VALAGUSSA, P ;

BONADONNA, G .

BRITISH MEDICAL JOURNAL, 1976, 1 (6013) :801-804

[9]

BULL JM, 1978, CANCER, V41, P1649, DOI 10.1002/1097-0142(197805)41:5<1649::AID-CNCR2820410501>3.0.CO

[10]

2-J

← 1 2 3 4 5 6 7 8 →